Medicaid pays for two-thirds of nursing home residents, but some recipients don’t even know they’re on it.
An expert panel renews its guidelines that children and teens be screened for obesity at doctors’ offices and advised to receive treatment.
Once-fatal childhood diseases, like cystic fibrosis, congenital heart disease and sickle cell anemia, now can be survived into adulthood. But when those patients become too old to see pediatricians, it can be difficult for them to find physicians familiar with their conditions.
Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
Armed with strict guidelines and motivated by sheer urgency, a specialized team of nurses makes the rounds, seeking to thwart the No. 1 killer in U.S. hospitals.
A small number of medical practices have been moving to “direct primary care,” in which patients pay a monthly retainer for unlimited services. But the collapse of Qliance in Seattle may portend problems with the business model.
Documents examined by Kaiser Health News shed light on the workings of the Trump administration’s “Drug Pricing and Innovation Working Group.”
The Seattle case, the first to reach trial in the U.S., offers possible glimpse into fate of some two dozen lawsuits against manufacturing giant Olympus, accused of failing to address scope contamination linked to numerous deaths. The company faults poor hospital cleaning practices.
This year’s American Diabetes Association scientific meeting came with a hefty price — a policy of no photography and limits on social media. That did not go over well on Twitter.
The study also found that the largest percentage of medical coverage claims related to opioid abuse and dependence nationally come from older patients — those ages 51 to 60.
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
The researchers looked at 11 services that medical groups have said are often unnecessary and found that Hispanics and blacks got them at higher rates than whites.
Actions by the Trump administration are putting pressure on the fragile market for individuals who buy their own coverage, but analysts say it should be able to rebound.
One insurer is turning the tables on drugmakers with what may be a new job category: a sales force for cost-effective medicine.
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices.
A 22-year old man from Orange County, Calif., alleges in a lawsuit that his health insurer stopped paying for a crucial — and expensive — immunotherapy drug, leading him to become seriously ill. Treatments for patients with similar conditions are increasingly denied or interrupted, experts and patient advocates say.
About 300 health care systems around the country have set up medical-legal partnerships to help patients who are dealing with legal problems that affect their health.
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
A new JAMA study examines how drug rebates can direct money to middlemen and force Medicare patients to cough up more money.
En el otoño, corredores y aseguradoras podrán guiar a los consumidores en el proceso para obtener un plan de salud de principio a fin. Pero algunos piensan que no mostrarán todas las opciones por igual, sino aquéllas por las que obtendrían una comisión.